GLL Health Sciences Fund Amends D/A, Confirms 3(c)(7) Status

TL;DR

**GLL Health Sciences Fund LLC is a private fund for rich investors, so don't expect public company transparency.**

AI Summary

GLL Health Sciences Fund LLC filed an amended Form D/A on March 24, 2026, updating its notice of exempt offering of securities. This filing indicates the fund operates under Section 3(c)(7) of the Investment Company Act, meaning it caters exclusively to 'qualified purchasers' and is exempt from certain SEC regulations. For investors, this matters because it confirms GLL Health Sciences Fund LLC's status as a private fund, typically implying higher risk and less transparency than publicly registered funds, suitable only for sophisticated investors.

Why It Matters

This filing confirms GLL Health Sciences Fund LLC's status as a private fund for qualified purchasers, meaning it's not subject to the same public disclosure requirements as traditional mutual funds, which impacts transparency for potential investors.

Risk Assessment

Risk Level: high — Funds operating under Section 3(c)(7) are exempt from many Investment Company Act regulations, leading to less public disclosure and higher inherent risk for investors.

Analyst Insight

Smart investors should recognize that GLL Health Sciences Fund LLC is a private fund with limited public disclosure due to its 3(c)(7) exemption, meaning it's only suitable for sophisticated investors who can conduct extensive due diligence independently.

Key Numbers

• 3(c)(7) — Investment Company Act Section (Indicates the fund is exempt from registration and caters to qualified purchasers.)
• 021-506995 — File No. (Unique identifier for this specific offering with the SEC.)
• 2026-03-24 — Filing Date (The date the amended D/A form was submitted and accepted by the SEC.)

Key Players & Entities

• GLL Health Sciences Fund LLC (company) — the filer of the D/A form
• 3(c)(7) (other) — section of the Investment Company Act under which the fund operates
• 0001690008 (other) — CIK of GLL Health Sciences Fund LLC
• 2026-03-24 (date) — filing and acceptance date of the D/A form

Forward-Looking Statements

• GLL Health Sciences Fund LLC will continue to target 'qualified purchasers' for its offerings. (GLL Health Sciences Fund LLC) — high confidence, target: 2027-03-24
• The fund will maintain its exemption status under Section 3(c)(7) for the foreseeable future. (GLL Health Sciences Fund LLC) — high confidence, target: 2027-03-24

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D/A)
• primary_doc.xml (D/A) — 8KB
• 0001690008-26-000003.txt ( ) — 9KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   GLL Health Sciences Fund LLC Jurisdiction of Incorporation/Organization DELAWARE   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year)   Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   GLL Health Sciences Fund LLC Street Address 1 Street Address 2   3200 NORTH LAKE SHORE DRIVE #201     CHICAGO   ILLINOIS     60657 3. Related Persons Last Name First Name Middle Name Investors LLC GLL Street Address 1 Street Address 2   3200 North Lake Shore Drive #201       Chicago   ILLINOIS   60657   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Manager of Issuer Last Name First Name Middle Name Gilboy William Stephen Street Address 1 Street Address 2   3200 North Lake Shore Drive #201       Chicago   ILLINOIS   60657   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Director of Investments, Managing Member of the Manager, Promoter of issuer Last Name First Name Middle Name Gilboy Jason Street Address 1 Street Address 2   3200 N Lake Shore Drive #201       Chicago   ILLINOIS   60657   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Chief Compliance Officer, Managing Member of the Manager, Promoter of the issuer Last Name First Name Middle Name Newlander Michael Street Address 1 Street Address 2   3200 N Lake Shore Drive #201       Chicago   ILLINOIS   60657   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Director of Investments, Managing Member of the Manager, Promoter of issuer 4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund Hedge Fund Other Investment Fund Private Equity Fund Venture Capital Fund *Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes  No   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c)(14) Section 3(c)(7)     7. Type of Filing   New Notice Date of First Sale   2016-11-01   First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)       10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any out

View Full Filing

View this D/A filing on SEC EDGAR